Company intelligence / Profile preview

EMMAC Life Sciences

London, England, United Kingdom

Ownership: Private
Employees: ~70
Development stage: Other

Overview

EMMAC Life Sciences is a vertically integrated European medical cannabis company focused on cultivation, EU‑GMP processing, and distribution of cannabis-based medicinal products across the UK, Germany, Italy, Spain, Portugal and other European markets; it operates commercially rather than through conventional drug development trials.[2][10][3]

Therapeutic areas: OncologyNeurologyPsychiatry
Modalities: Small moleculePlant-derived product
Industry: Non-Drug Biotech

Partnerships

Sapphire Medical Clinics (UK data-driven medical cannabis partnership for flower and oil products)[3]

Beyond the preview

Go deeper on EMMAC Life Sciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on EMMAC Life Sciences.

Explore the full profile